DK1082304T3 - Ny krystallinsk polymorf form af 1-methyl-5-p-toluoylpyrrol-2-acetamideddikesyre guaiacylester (MED 15) - Google Patents
Ny krystallinsk polymorf form af 1-methyl-5-p-toluoylpyrrol-2-acetamideddikesyre guaiacylester (MED 15)Info
- Publication number
- DK1082304T3 DK1082304T3 DK98962664T DK98962664T DK1082304T3 DK 1082304 T3 DK1082304 T3 DK 1082304T3 DK 98962664 T DK98962664 T DK 98962664T DK 98962664 T DK98962664 T DK 98962664T DK 1082304 T3 DK1082304 T3 DK 1082304T3
- Authority
- DK
- Denmark
- Prior art keywords
- toluoylpyrrole
- methyl
- ester
- guaiacetic
- med
- Prior art date
Links
- 150000002148 esters Chemical class 0.000 title abstract 2
- -1 1-methyl-5-p-toluoylpyrrole-2-acetamide acetic acid Chemical compound 0.000 title 1
- CWJNMKKMGIAGDK-UHFFFAOYSA-N amtolmetin guacil Chemical compound COC1=CC=CC=C1OC(=O)CNC(=O)CC(N1C)=CC=C1C(=O)C1=CC=C(C)C=C1 CWJNMKKMGIAGDK-UHFFFAOYSA-N 0.000 title 1
- GZQHOTPDLORUIU-UHFFFAOYSA-N 2-acetamidoacetic acid;(4-methylphenyl)-(1-methylpyrrol-2-yl)methanone Chemical compound CC(=O)NCC(O)=O.C1=CC(C)=CC=C1C(=O)C1=CC=CN1C GZQHOTPDLORUIU-UHFFFAOYSA-N 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/323—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97RM000811A IT1297140B1 (it) | 1997-12-24 | 1997-12-24 | Forma cristallina del guaiacil estere dell'acido l-metil-5-p-toluoil- pirrol-2-acetammidoacetico, procedimento per la sua preparazione e |
| PCT/IT1998/000363 WO1999033797A1 (en) | 1997-12-24 | 1998-12-16 | NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1082304T3 true DK1082304T3 (da) | 2004-04-05 |
Family
ID=11405418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98962664T DK1082304T3 (da) | 1997-12-24 | 1998-12-16 | Ny krystallinsk polymorf form af 1-methyl-5-p-toluoylpyrrol-2-acetamideddikesyre guaiacylester (MED 15) |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6288241B1 (cs) |
| EP (1) | EP1082304B1 (cs) |
| JP (1) | JP4693236B2 (cs) |
| KR (1) | KR100554704B1 (cs) |
| CN (1) | CN1200930C (cs) |
| AT (1) | ATE255562T1 (cs) |
| AU (1) | AU781283B2 (cs) |
| BR (1) | BR9814476A (cs) |
| CA (1) | CA2315835C (cs) |
| CZ (1) | CZ297132B6 (cs) |
| DE (1) | DE69820301T2 (cs) |
| DK (1) | DK1082304T3 (cs) |
| ES (1) | ES2210853T3 (cs) |
| HU (1) | HU228112B1 (cs) |
| IL (1) | IL136828A (cs) |
| IT (1) | IT1297140B1 (cs) |
| PL (1) | PL197768B1 (cs) |
| PT (1) | PT1082304E (cs) |
| SK (1) | SK284777B6 (cs) |
| TR (1) | TR200001867T2 (cs) |
| WO (1) | WO1999033797A1 (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113474354A (zh) * | 2019-02-28 | 2021-10-01 | 国立大学法人东京工业大学 | 酰胺的制造方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1210673B (it) * | 1982-02-26 | 1989-09-20 | Medosan Ind Biochimi | Antinfiammatoria amidi pirrolacetiche ad attivita' |
| IT1148117B (it) * | 1982-03-05 | 1986-11-26 | Medosan Ind Biochimi | Attivita'antiflogistica,analgesica,antipiretica,mucolitica e seda tiva della tosse dell'1 metil-5-p-tolilpirrol-2-acetato di 2'metossi-fenile |
| IT1197688B (it) * | 1983-07-29 | 1988-12-06 | Medosan Ind Biochimi | Attivita' antiflogistica,analgesica,antipiretica ed antiaggregante piastrinica di 1-metil-5-metilbenzoilpirrol-2-acetamido acetanilidi |
| IT1278144B1 (it) * | 1995-07-14 | 1997-11-17 | Medosan Ricerca Srl | Impiego dell'amtolmetineguacil (med 15) come farmaco antisecretivo sulla secrezione gastrica e quindi gastroprotettivo. |
| JP2001513497A (ja) * | 1997-08-08 | 2001-09-04 | メドサン、リセルカ エス．アール．エル． | 胃分泌過多および腎損傷の予防作用を有する抗炎症剤の製造のための化合物２−メトキシフェニル−１−メチル−５ｐ−メチルベンゾイル−ピロール−２−アセトアミドアセテートの使用 |
-
1997
- 1997-12-24 IT IT97RM000811A patent/IT1297140B1/it active IP Right Grant
-
1998
- 1998-12-16 EP EP98962664A patent/EP1082304B1/en not_active Expired - Lifetime
- 1998-12-16 AU AU17828/99A patent/AU781283B2/en not_active Expired
- 1998-12-16 JP JP2000526481A patent/JP4693236B2/ja not_active Expired - Lifetime
- 1998-12-16 PT PT98962664T patent/PT1082304E/pt unknown
- 1998-12-16 SK SK895-2000A patent/SK284777B6/sk not_active IP Right Cessation
- 1998-12-16 DE DE69820301T patent/DE69820301T2/de not_active Expired - Lifetime
- 1998-12-16 US US09/581,289 patent/US6288241B1/en not_active Expired - Lifetime
- 1998-12-16 HU HU0101025A patent/HU228112B1/hu unknown
- 1998-12-16 CZ CZ20002336A patent/CZ297132B6/cs not_active IP Right Cessation
- 1998-12-16 IL IL13682898A patent/IL136828A/xx not_active IP Right Cessation
- 1998-12-16 AT AT98962664T patent/ATE255562T1/de active
- 1998-12-16 DK DK98962664T patent/DK1082304T3/da active
- 1998-12-16 CA CA002315835A patent/CA2315835C/en not_active Expired - Lifetime
- 1998-12-16 BR BR9814476-6A patent/BR9814476A/pt not_active Application Discontinuation
- 1998-12-16 TR TR2000/01867T patent/TR200001867T2/xx unknown
- 1998-12-16 ES ES98962664T patent/ES2210853T3/es not_active Expired - Lifetime
- 1998-12-16 KR KR1020007006998A patent/KR100554704B1/ko not_active Expired - Lifetime
- 1998-12-16 CN CNB988126567A patent/CN1200930C/zh not_active Expired - Lifetime
- 1998-12-16 WO PCT/IT1998/000363 patent/WO1999033797A1/en not_active Ceased
- 1998-12-16 PL PL341424A patent/PL197768B1/pl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0876131T3 (da) | Sammensætninger til lægemiddelindgivelse til forbedret stabilitet af androgener | |
| EE200100246A (et) | Asendatud fenüültsükloheksüülühendite uued esterderivaadid | |
| ES2158537T3 (es) | Derivados de acidos ciclopropilalcanoicos. | |
| AR014349A1 (es) | Proceso para la preparacion de [2-(2-tienil)etilamino](2-halogenofenil) acetatos de metilo racemicos u opticamente activos. | |
| AU6075294A (en) | Peptide analogs as irreversible interleukin-beta protease inhibitors | |
| DE69830504D1 (de) | Antithrombotische mitteln | |
| DE69705829D1 (de) | Meta-substituierte phenylsulphonamidderivate | |
| DK0923554T3 (da) | N-Benzylpiperidin- og tetrahydropyridinderivater | |
| GB9718903D0 (en) | Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents | |
| BR9912010A (pt) | Polimorfo de um produto farmacêutico | |
| HRP20030983B1 (hr) | Farmaceutski pripravak koji uključuje inhibitor lipaze i saharozne estere masne kiseline | |
| PT736029E (pt) | Sulfamatos de pseudofructopiranose anticonvulsivos | |
| DK0937060T3 (da) | Nye cis-3,4-chroman-derivater, der er nyttige i forebyggelsen eller behandlingen af østrogen-relaterede sygdomme eller syndromer | |
| AU4170299A (en) | Composition for the transdermal administration of non-steroidal anti-inflammatory drugs | |
| DK1082304T3 (da) | Ny krystallinsk polymorf form af 1-methyl-5-p-toluoylpyrrol-2-acetamideddikesyre guaiacylester (MED 15) | |
| FR2768734B1 (fr) | Nouveaux composes tricycliques, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant | |
| ATE165083T1 (de) | N-arylalkylphenylacetamidderivate | |
| AU7470098A (en) | Antithrombotic agents | |
| DK0937057T3 (da) | Hidtil ukendte (-)-enantiomerer af cis-3,4-chromanderivater anvendelige i forebyggelse eller behandling af østrogenrelaterede sygdomme eller syndromer | |
| WO1998014454A3 (en) | (o-ACYL-p-N-ACYLAMINO-PHENYL)-O-PHOSPHOETHANOLAMINES | |
| FI905930A7 (fi) | Menetelmä uusien, farmakologisesti käyttökelpoisten bispilokarpiinihapon esterijohdannaisten valmistamiseksi | |
| NO20012266L (no) | Fremgangsmåte for fremstilling av L-DOPA-etylester | |
| BR9910603A (pt) | Método aprimorado paraa preparar derivados de norbenzomorfano valiosos farmaceuticamente | |
| IT1190663B (it) | Composto ad attivita' antiinfiammatoria,analgesica e mucoregolatrice,procedimento per la sua preparazione e relative composizioni farmaceutiche | |
| DK0971919T3 (da) | Fremgangsmåde til fremstilling af 4H-4-oxo-quinolizin-3-carboxylsyrederivater |